Effect of Kinesiotape Technique on Wrist Among Chronic Stroke Patients

August 31, 2022 updated by: Nouman Khan, Shifa Tameer-e-Millat University

Effect of Wrist Flexors Inhibition in Comparison to Wrist Extensors Facilitation Through Kinesiotaping Technique in Chronic Hemiplegic Stroke Patients With Limited Wrist Extension

The aim of this randomized controlled is to assess the effect of kinesiotape technique upon wrist joint among the patients with chronic stroke. Patients are devided into groups, in group A kinesiotaping facilitation technique is applied on wrist extensor muscles while inhibition technique is applied on wrist flexor muscles and the result is the compared between the groups and within the group.

Study Overview

Detailed Description

Stroke is a very common disease worldwide causing severe musculoskeletal disability due to which quality of life of patient compromises, patient becomes dependent of assistance in daily living activities and few becomes bed ridden. Stroke also causes death of the patient. Apart from musculoskeletal issues patient's cognitive abilities are also effected. It is tough to manage these patients as stroke varies in types and symptoms. Symptoms and severity depend upon type of stroke and factors like lifestyle, age and health issues. According to the symptoms different physiotherapy techniques and rehabilitation is used along with medical treatment and counseling of the patient. Kinesiotape also has the advantage that it can be worn 3-5 days due to which it's effects remains for long time as compare to other treatments which are given and has effect for a specific time for example a session of physical therapy including exercises is for an hour but this tape can be worn for days once applied.

Randomized controlled trial was done, 24 patients were recruited according to inclusion exclusion criteria. Patients were further divided into two groups; group 1 was given muscular facilitation treatment for wrist extensors and group 2 was given sessions for muscle inhibition treatment for wrist flexors. 6 sessions were given, 1 session per week over the period of 6 weeks to each patient.

Wrist range of motion for extension, flexion, ulnar and medial deviation was measured using goniometer before and after the 6 weeks. Manual muscle test for wrist extensors, modified ashworth scale and upper limb functional index scoring was done before and after sessions. Data was collected from a private clinic of PWD Rawalpindi.

The statistical values of result showed no significant change in between both the groups, before and after treatment. But a significant improvement was about observed within the group analysis It can be concluded from this study that Kinesiotape is an effective treatment method both in inhibiting and facilitating muscular performance. Hence both treatments were equally effective. it helps in increasing range of motion and in reducing spasticity.

Study Type

Interventional

Enrollment (Anticipated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Fedral
      • Islamabad, Fedral, Pakistan, 44000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age b/w 40 to 90
  • Limited ROM (wrist extension)

Exclusion Criteria:

  • Disoriented
  • Who needs more then moderate support to achieve basic ADL and are bed bound
  • Communication gap
  • Allergic to Kinesiotaping after being positive to patch test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Group 1
Hyperactive muscle correction for wrist extensors: Kinesiotape was applied to facilitate wrist extensor muscles from proximal to distal with 15-35% tension in therapeutic zone and no tension at anchor and end.
The extensor muscles of the wrist area will be targeted.
EXPERIMENTAL: Group 2
Hypoactive muscle correction for wrist flexors: Wrist flexors muscles were inhibited by applying tape from distal to proximal with 15-25% tension in therapeutic zone and no tension at anchor and end.
The flexor muscles of the wrist area will be targeted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wrist extensors manual muscle test score
Time Frame: 6 weeks
Wrist extensors strength was measured as baseline before the start of intervention and was compared with the measurement after 6 weeks of application of kinesiotape.
6 weeks
Wrist ROMS through Goniometer
Time Frame: 6 weeks
Wrist ROM was measured using universal goniometer, baseline values for wrist flexion, extension, ulnar deviation and medial deviation was measured and then compared to the values measured after 6 weeks of intervention.
6 weeks
Spasticity through modified ashwoth scale
Time Frame: 6 weeks
Wrist spasticity was measured through modified ashworth scale before the intervention and then was compared with the values taken after 6th week
6 weeks
Upper extremity functional index (UEFI)
Time Frame: 6 weeks
Patient was asked to perform different activities as opening the door and combing hair, score was done according to the difficulty level faced by patients while performing the activities. Measurement was taken before first session and was compared with the values taken after 6 weeks of intervention
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Saman Tauseef, MSPT, Shifa Tameer-e-Millat University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 31, 2022

Primary Completion (ANTICIPATED)

October 19, 2022

Study Completion (ANTICIPATED)

October 26, 2022

Study Registration Dates

First Submitted

August 31, 2022

First Submitted That Met QC Criteria

August 31, 2022

First Posted (ACTUAL)

September 2, 2022

Study Record Updates

Last Update Posted (ACTUAL)

September 2, 2022

Last Update Submitted That Met QC Criteria

August 31, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe